tradingkey.logo

Prestige Consumer Healthcare Inc

PBH
View Detailed Chart

63.100USD

-1.000-1.56%
Close 09/19, 16:00ETQuotes delayed by 15 min
3.11BMarket Cap
14.58P/E TTM

Prestige Consumer Healthcare Inc

63.100

-1.000-1.56%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.56%

5 Days

-0.24%

1 Month

-3.53%

6 Months

-24.55%

Year to Date

-19.20%

1 Year

-14.64%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
13 / 175
Overall Ranking
85 / 4720
Industry
Pharmaceuticals

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 5 analysts
Buy
Current Rating
83.600
Target Price
+30.42%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Prestige Consumer Healthcare Inc. is consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. It operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Fairly Valued
The company’s latest PE is 14.69, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 53.74M shares, decreasing 3.58% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 5.62M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.12.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Prestige Consumer Healthcare Inc. is consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. It operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Ticker SymbolPBH
CompanyPrestige Consumer Healthcare Inc
CEOMr. Ronald M. (Ron) Lombardi, CPA
Websitehttps://www.prestigebrands.com/
KeyAI